Related Experiment Video

Updated: Aug 23, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Issues in the Management of Endocarditis Caused by Resistant Gram-positive Organisms

Martin E. Stryjewski1, Vivian H. Chu, Christopher H. Cabell

  • 1Box 3281, Room 34228 Red Zone Duke South, Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. fowle003@mc.duke.edu

Current Infectious Disease Reports
|July 22, 2004
PubMed

Insights

Infective endocarditis (IE) is often caused by gram-positive bacteria, but rising antibiotic resistance complicates treatment. Limited clinical data exists for newer antibiotics against this challenging infection.

Area of Science:

  • Infectious Diseases
  • Bacteriology
  • Pharmacology

Background:

  • Infective endocarditis (IE) is a serious infection primarily caused by gram-positive bacteria.
  • Key pathogens include enterococci, streptococci, and staphylococci.
  • Increasing antimicrobial resistance in these bacteria poses significant treatment challenges.

Purpose of the Study:

  • To review the current landscape of antibiotic resistance in infective endocarditis.
  • To evaluate the limited clinical experience with newer gram-positive antibiotics for IE treatment.

Main Methods:

  • Literature review of studies on infective endocarditis and antibiotic resistance.
  • Analysis of clinical data regarding the efficacy of newer antimicrobial agents.

Main Results:

  • Gram-positive bacteria are the predominant cause of infective endocarditis.
  • Antibiotic resistance among these pathogens is increasing, reducing the effectiveness of standard treatments.
  • There is a scarcity of clinical evidence for the use of novel gram-positive antibiotics in managing IE.

Conclusions:

  • The rising resistance of gram-positive bacteria complicates infective endocarditis management.
  • Further clinical research is needed to establish the role of newer antibiotics in treating IE.

More Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...